Biotech/Biomedical
News Category

Regentis Biomaterials Advances GelrinC as Potential New Approach to Knee Cartilage Repair
Regentis Biomaterials is advancing GelrinC, an off-the-shelf hydrogel implant designed to regenerate knee cartilage, with European approval and an FDA...

ORGANA International Expands U.S. Retail Strategy at ECRM Session
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to expand its retail presence and...

Med-X Advances Nature-Cide Pest-Control Platform Ahead of Planned Nasdaq Listing
Med-X is expanding its Nature-Cide natural pest-control brand and has obtained OMRI certification for key products as it prepares for a planned Nasdaq...

Telomir-Zn Shows Growth Inhibition in Human and Canine Osteosarcoma Models, Paving Way for Translational Research
Telomir Pharmaceuticals' Telomir-Zn inhibits growth in human and canine osteosarcoma cell lines at low concentrations, supporting further studies that...

FDA Clearance of Quantum BioPharma's Lucid-MS IND Marks Key Milestone for Multiple Sclerosis Treatment
Quantum BioPharma has received FDA clearance for its Investigational New Drug application for Lucid-MS, allowing the company to initiate a Phase 2 tri...

GeoVax Partners with CEPI to Support GEO-MVA Phase 3 Trial, Aiming to Diversify Global Mpox Vaccine Supply
GeoVax has entered an agreement with CEPI to use its Centralised Laboratory Network for independent testing in the GEO-MVA Phase 3 trial, a move that ...

Aortic Structure, Not Menopause, May Drive Midlife Pulse Pressure Rise in Women
New research from the Framingham Heart Study suggests that aortic stiffening, rather than menopause, is the primary driver of increased pulse pressure...

Dental Design Studios Expands to Nine Phoenix Offices, Offering Full Arch Implants and Emergency Care
Dental Design Studios has expanded its services to nine Phoenix-area locations, increasing access to full arch implants, cosmetic dentistry, and same-...

Engineered Suppressor tRNAs Show Promise for Duchenne Muscular Dystrophy
Preclinical research published in Science Advances demonstrates that engineered suppressor tRNA gene therapy can restore full-length dystrophin and im...

Wellness Index Report Highlights Translational Longevity as Key to Delivering Science to Patients
The August Wellness Index Report emphasizes that translating longevity discoveries into clinical care is essential for real progress, with a summit pl...

Creative Biolabs Expands Functionalized Lipid Delivery Systems to Overcome Key Research Barriers
Creative Biolabs has broadened its lipid-based delivery development services to help researchers address stability, targeting, and controlled release ...

Dr. Thanapoom Boonipat Scholarship for Future Doctors Offers $1,000 to Aspiring Physicians Nationwide
The Dr. Thanapoom Boonipat Scholarship for Future Doctors provides a $1,000 one-time award to undergraduate students nationwide who are committed to c...

LiverRight and Aegle Medical Solutions Partner to Expand Liver Disease Detection and Care Nationwide
The strategic partnership combines Aegle Medical's advanced liver assessment technology with LiverRight's virtual hepatology network to streamline liv...

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Solutions to Advance Biomedical Discovery
Creative Biolabs has broadened its single-cell RNA sequencing, single-nucleus RNA sequencing, and single-cell multi-omics services to help researchers...

Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
A new review reveals that the tumor microenvironment actively reprograms natural killer cells into distinct subsets, offering a framework for more pre...

Nanox Expands Latin American Reach with Costa Rica Distribution Agreement for Nanox.ARC
Nanox signs a distribution agreement with SOLME RC to bring its Nanox.ARC 3D medical imaging system to Costa Rica, marking its third Latin American ma...

Life Sciences Virtual Investor Forum to Showcase Seven Companies Advancing Cancer, Antibiotic, and Drug Delivery Innovations
The September 17 virtual forum will give investors direct access to management teams from seven life sciences companies, highlighting emerging therapi...

SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, marking a significant expansion...

SS Innovations Reports 79% Surge in Robotic Procedures, Expands Global Footprint
SS Innovations International announced a 79% increase in procedures using its SSi Mantra surgical robot and a 42% expansion of its installed base, sig...

GeoVax Appeals Nasdaq Delisting, Reaffirms Strategic Focus on Vaccine and Oncology Programs
GeoVax Labs is appealing a Nasdaq delisting determination while continuing to advance its GEO-MVA vaccine and Gedeptin cancer therapy, highlighting th...

American Heart Association PREVENT Equations Integrated into Epic EHR Platform
The American Heart Association's PREVENT equations are now available in Epic's electronic health record platform, making advanced cardiovascular risk ...

BioCorRx Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory Board
BioCorRx Inc. has appointed Richard J. Baum, former Acting Director of the White House Office of National Drug Control Policy, to its Strategic Adviso...

Nightfood Holdings Advances Service Robotics as Businesses Seek Greater Efficiency
Nightfood Holdings (OTCQB: NGTF) is advancing AI-powered service robotics to automate tasks across multiple industries, capitalizing on labor shortage...

Greenland Mines Advances Critical Metals Projects with Skaergaard Bulk Sampling and Sarfartoq Fieldwork
Greenland Mines completes its Skaergaard bulk-sampling program and advances fieldwork at Sarfartoq, marking significant progress in its critical metal...

NWB Finland Oy to Showcase Sustainable Bag-in-Box Water at ECRM 2026
NWB Finland Oy will present AINA Natural Water in 5-liter and 10-liter bag-in-box formats at the 2026 ECRM Vitamin, Weight Management & Sports Nutriti...

FingerMotion Cuts Cash Burn by Nearly 30% Under New Management, Strengthens Liquidity
FingerMotion Inc. (NASDAQ: FNGR) has reduced its monthly cash burn by nearly 30% and bolstered its cash position to approximately $5.1 million within ...

Regentis Biomaterials Advances GelrinC Pivotal Trial and European Commercialization Plans in First Half 2026
Regentis Biomaterials reported progress in its Phase III GelrinC trial and European regulatory approval for a manufacturing process that boosts yield ...

Gold-Silver Ratio Remains a Key Indicator for Silver Prices, Study Finds
A recent study highlighted in the Silver Institute's latest report reaffirms the gold-to-silver ratio as a valuable tool for assessing silver's price ...

Rising Uninsured Rates Threaten Healthcare Access for All Americans
As health insurance premiums rise and recent legislative changes take effect, a growing number of Americans are becoming uninsured or underinsured, wi...

Nanox Expands Latin American Reach with Costa Rica Distribution Agreement for Nanox.ARC
Nanox Imaging signs a distribution agreement with SOLME RC to bring its 3D medical imaging system to Costa Rica, marking its third Latin American mark...

Quantum BioPharma's Lucid-MS Phase 2 Trial Signals New Direction in Multiple Sclerosis Treatment
Quantum BioPharma receives FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug that aims to protect and rebu...

TransCode Therapeutics Appoints Interim CFO as Fitzgerald Retires
TransCode Therapeutics has appointed John Tattory as interim CFO following the immediate retirement of Tom Fitzgerald, a change that could impact the ...

Regentis Biomaterials Advances GelrinC as Potential New Approach to Knee Cartilage Repair
Regentis Biomaterials is developing GelrinC, an off-the-shelf hydrogel implant designed to regenerate knee cartilage, offering a potential alternative...

TNT Targets U.S. Retail Expansion at ECRM, Leveraging German Quality in Competitive Sports Nutrition Market
German sports nutrition brand TNT (True Nutrition Technology) is attending the ECRM Vitamin, Weight Management & Sports Nutrition Session to build ret...

VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Drive BiTAC® Clinical Development
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer underscores its commitment to advancing its BiTAC® technology and onco...

Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction
Earth Science Tech's B2B-B2C healthcare platform fuels revenue growth and debt reduction, positioning the company for sustainable, self-funded expansi...

SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program, Signaling Global Expansion
SS Innovations International (NASDAQ: SSII) has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Man...

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial After FDA Clearance
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis therapy that targets demyelinat...

FDA Clearance of First Myelin-Rebuilding Multiple Sclerosis Drug Marks Historic Shift in Treatment
Quantum BioPharma's FDA clearance to launch a phase 2 trial of Lucid-MS signals a potential paradigm shift in multiple sclerosis treatment from immune...

FDA Clearance of Quantum BioPharma's Lucid-MS Marks Historic First in Multiple Sclerosis Treatment
Quantum BioPharma has received FDA clearance to launch a phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug designed to protect and r...

SS Innovations Reports 79% Surge in SSi Mantra Robotic Surgeries, Expands Global Footprint
SS Innovations International's SSi Mantra surgical robotic system has seen a 79% increase in cumulative procedures and a 42% growth in installed base,...

Helus Pharma CEO to Present at Morgan Stanley Global Healthcare Conference
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, highlighting the company's prog...

Onco-Innovations CMO Highlights ONC010's Dual Selectivity and Preclinical Success in BioMedWire Podcast
Onco-Innovations' CMO discussed the company's lead drug candidate ONC010, which targets PNKP with a dual selectivity approach, and its potential to ad...

FDA Clearance Paves Way for Quantum BioPharma's Phase 2 Trial of Lucid-MS in Multiple Sclerosis
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor that targets demyelination directly, has received FDA clearance to begin a ...

American Fusion's Texatron Enters Active Testing Phase, Signaling Potential Shift in Fusion Energy Development
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak pressures of 100,000 atmospheres and attracting new equ...

American Fusion's Texatron Program Advances to Active Testing, Signaling Potential Shift in Fusion Energy Race
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving 100,000 atmospheres of pressure, a critical step toward demo...


